Global Cerebral Infarction Treatment Market Size & Outlook
Global cerebral infarction treatment market, 2018-2030 (US$M)
Related Markets
Global cerebral infarction treatment market highlights
- The global cerebral infarction treatment market generated a revenue of USD 13,401.1 million in 2024 and is expected to reach USD 20,508.5 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 7.3% by 2030.
- In terms of segment, tissue plasminogen activators (tpa) accounted for a revenue of USD 5,258.7 million in 2024.
- Anticoagulants is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 13,401.1 million |
| Market revenue in 2030 | USD 20,508.5 million |
| Growth rate | 7.3% (CAGR from 2025 to 2030) |
| Largest segment | Tissue plasminogen activators (tpa) |
| Fastest growing segment | Anticoagulants |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tissue Plasminogen Activators (tPA), Anticoagulants, Antiplatelets, Anticonvulsants |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global cerebral infarction treatment market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 231.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cerebral Infarction Treatment Market Scope
Cerebral Infarction Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amneal Pharmaceuticals Inc Ordinary Shares - Class A | View profile | 7700 | 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, United States, 08807 | https://www.amneal.com |
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Otsuka Holdings Co Ltd | View profile | 39548 | 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, Japan, 101-0048 | http://www.otsuka.com/jp |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Global cerebral infarction treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cerebral infarction treatment market will help companies and investors design strategic landscapes.
Tissue plasminogen activators (tpa) was the largest segment with a revenue share of 39.24% in 2024. Horizon Databook has segmented the Global cerebral infarction treatment market based on tissue plasminogen activators (tpa), anticoagulants, antiplatelets, anticonvulsants covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Cerebral Infarction Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Tissue Plasminogen Activators (tPA)
- Anticoagulants
- Antiplatelets
- Anticonvulsants
- Others
- Global Cerebral Infarction Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Ischemic Stroke
- Hemorrhagic Stroke
- Global Cerebral Infarction Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Other
Reasons to subscribe to Global cerebral infarction treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global cerebral infarction treatment market databook
-
Our clientele includes a mix of cerebral infarction treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global cerebral infarction treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global cerebral infarction treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global cerebral infarction treatment market size, by regions, 2018-2030 (US$M)
Top 10 countries: Cerebral infarction treatment market size, 2024 (US$M)
Global cerebral infarction treatment market share, by drug class, 2024 & 2030 (%, US$M)
Cerebral infarction treatment market: Opportunity assessment by country
Global cerebral infarction treatment market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
